Growth Metrics

Prelude Therapeutics (PRLD) Shares Issued (2024 - 2026)

Prelude Therapeutics' Shares Issued history spans 3 years, with the latest figure at $31000.0 for Q1 2026.

  • On a quarterly basis, Shares Issued changed N/A to $31000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $181000.0, a 51.99% decrease, with the full-year FY2025 number at $150000.0, down 60.42% from a year prior.
  • Shares Issued hit $31000.0 in Q1 2026 for Prelude Therapeutics, down from $58000.0 in the prior quarter.
  • Over the last five years, Shares Issued for PRLD hit a ceiling of $319000.0 in Q4 2024 and a floor of -$195000.0 in Q3 2024.
  • Historically, Shares Issued has averaged $80000.0 across 3 years, with a median of $58000.0 in 2025.
  • The widest YoY moves for Shares Issued: up 63.64% in 2025, down 81.82% in 2025.
  • Tracing PRLD's Shares Issued over 3 years: stood at $319000.0 in 2024, then plummeted by 81.82% to $58000.0 in 2025, then tumbled by 46.55% to $31000.0 in 2026.
  • Business Quant data shows Shares Issued for PRLD at $31000.0 in Q1 2026, $58000.0 in Q4 2025, and $92000.0 in Q2 2025.